Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Dopamine Impurity 3

Dopamine Impurity 3 is listed in the pharmaceutical impurity collection under CAS 67992-45-4. Its represented structure has formula C8H7NO2 and a calculated molecular weight of 149.15 g/mol.

2D chemical structure

O N H O

Chemical identity

Catalog name
Dopamine Impurity 3
Common name
Dopamine Impurity 3
Chemical name
2,3-dihydro-1H-indole-5,6-dione
CAS
67992-45-4
SMILES
O=C1C=C2CCNC2=CC1=O
InChI
InChI=1S/C8H7NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h3-4,9H,1-2H2
InChIKey
XDEURYRPQDIBSL-UHFFFAOYSA-N
Associated API
Dopamine

Record ID: Abb64cf193365

Computed properties

C8H7NO2 Molecular formula
149.149 g/molMolecular weight
149.0477 DaMonoisotopic exact mass
46.17 ŲTopological polar surface area
-0.0582 Calculated LogP (Wildman–Crippen)
38.7997 cm³/molMolar refractivity (Wildman–Crippen)
3 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 2 4 6 8 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight149.1495.64
Calculated LogP (Wildman–Crippen)-0.058213.54
Topological polar surface area46.1727.37
Hydrogen-bond acceptors333.13
Hydrogen-bond donors138.08
Rotatable bonds (strict)03.45

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC8H7NO2dimensionless
Molecular weight149.149g/mol
Monoisotopic exact mass149.0477Da
Topological polar surface area46.17Ų
Calculated LogP (Wildman–Crippen)-0.0582dimensionless
Molar refractivity (Wildman–Crippen)38.7997cm³/mol
Hydrogen-bond acceptors3count
Hydrogen-bond donors1count
Rotatable bonds (strict)0count
Heavy atoms11count
Heteroatoms3count
Rings2count
Aromatic rings0count
Aliphatic rings2count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles0count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.25fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area63.7759Ų
Valence electrons56count
Radical electrons0count
Bertz complexity269.2139index
Balaban J2.4388index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Dopamine Impurity 3

Qualification and safety assessment of Dopamine Impurity 3

Explore toxicological qualification of Dopamine Impurity 3 and ICH M7 mutagenic impurity assessment of Dopamine Impurity 3 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Dopamine Impurity 3 and acceptable intake and limit justification for Dopamine Impurity 3. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Dopamine Impurity 3

Explore Altox services and software through the Altox Pharma-Hub.